Global Cardiac Mapping Systems Market Report and Forecast 2023-2031

Global Cardiac Mapping Systems Market Report and Forecast 2023-2031

Global Cardiac Mapping Systems Market Outlook

The cardiac mapping systems market size attained a value of USD 1.845 billion in 2022. The market is likely to grow further at a CAGR of 8.5% during the forecast period of 2023-2031 to attain a value of USD 3.844 billion by 2031, driven by the rising demand for better diagnosis of heart related ailments.

Cardiac Mapping Systems Market: Introduction and Application

Cardiac mapping systems are medical devices that are used to create maps or diagrams of the electrical activity of the heart. Cardiac mapping is a critical diagnostic tool used to diagnose and treat various cardiac arrhythmias. The market growth is being driven by factors such as increasing prevalence of cardiac arrhythmias, technological advancements in cardiac mapping systems, and the rise in the geriatric population.

Cardiac mapping systems are primarily used for the diagnosis and treatment of cardiac arrhythmias, which are abnormal heart rhythms that can cause serious health problems. These systems are used to create maps or diagrams of the electrical activity of the heart, which can help doctors to identify the cause of the arrhythmia and develop an appropriate treatment plan.

The major applications of cardiac mapping systems include:

  • Diagnosis of Cardiac Arrhythmias: Cardiac mapping systems are used to diagnose various types of cardiac arrhythmias, such as atrial fibrillation, ventricular fibrillation, atrial flutter, and supraventricular tachycardia, among others. These systems can help doctors to identify the location and extent of the abnormal electrical activity in the heart and determine the best treatment approach.
  • Treatment of Cardiac Arrhythmias: Cardiac mapping systems are also used in the treatment of cardiac arrhythmias. It can help doctors to guide catheter ablation procedures, which involve using radiofrequency energy to destroy the small area of heart tissue that is causing the arrhythmia. Cardiac mapping systems can help doctors to precisely locate the area of the heart that needs to be ablated, improving the success rate of the procedure.
  • Monitoring of Heart Function: Cardiac mapping systems can also be used to monitor the function of the heart during and after treatment for cardiac arrhythmias. These systems can provide real-time information on the electrical activity of the heart, helping doctors to evaluate the effectiveness of the treatment and adjust as needed.
Overall, cardiac mapping systems are a critical tool in the diagnosis and treatment of cardiac arrhythmias. They offer a non-invasive way to create detailed maps of the electrical activity of the heart, helping doctors to develop more precise and effective treatment plans.

Cardiac Mapping Systems Market Segmentations

The market can be categorised into product, indication, application, distribution channel, and major regions.

Market Breakup by Type
  • Contact Cardiac Mapping Systems
  • Electro-anatomical Mapping Systems
  • Traditional Endocardial Catheter Mapping Systems
  • Basket Catheter Mapping Systems
  • Non-Contact Cardiac Mapping Systems
Market Breakup by Indication Type
  • Atrial Flutter
  • Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
  • Atrial Fibrillation
  • Other Arrhythmias
Market Breakup by End-User
  • Hospitals
  • Testing Laboratories
  • Research Laboratories
  • Individual
Cardiac Mapping Systems Market Breakup by Region
  • North America
  • United States of America
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others
Cardiac Mapping Systems Market Scenario

The market is expected to witness significant growth in the coming years. The market growth is being driven by factors such as the increasing prevalence of cardiac arrhythmias, technological advancements in cardiac mapping systems, and the rise in the geriatric population.

North America has been dominating the global cardiac mapping systems market, followed by Europe and the Asia Pacific. The high prevalence of cardiac arrhythmias, favourable reimbursement policies, and the presence of many key players in the region are driving the growth of the market in North America and Europe.

The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of cardiac arrhythmias and the rising healthcare expenditure in the region. Moreover, the growing demand for minimally invasive procedures, advancements in healthcare infrastructure, and increasing investments in research and development activities are expected to fuel the growth of the cardiac mapping systems market in the Asia Pacific region.

Key Players in the Global Cardiac Mapping Systems Market

The report gives an in-depth analysis of the key players involved in the cardiac mapping systems market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Biosense Webster
  • Abbott Laboratories
  • Medtronics PLC
  • Boston Scientific Corporation
  • Acutus Medical
  • Microport Scientific Corporation
  • CoreMap Inc.
  • APN Health LLC
  • BioSig Technologies Inc.
  • Biotronik SE and Co KG
  • Koninklijke Philips NV
  • Angiodynamics


1 Preface
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology
3 Executive Summary
4 Global Cardiac Mapping System Market
4.1 Global Cardiac Mapping System Market Overview
4.1.1 Global Cardiac Mapping System Market Analysis
4.1.1.1 Market Overview
4.1.1.1.1 Global Cardiac Mapping System Historical Market Value (2016-2022)
4.1.1.1.2 Global Cardiac Mapping System Forecast Market Value (2023-2031)
4.1.2 Global Cardiac Mapping System Market by Type
4.1.2.1 Market Overview
4.1.2.1.1 Contact Cardiac Mapping Systems
4.1.2.1.2 Electroanatomical Mapping Systems
4.1.2.1.3 Basket Catheter Mapping Systems
4.1.2.1.4 Traditional Endocardial Catheter Mapping Systems
4.1.2.1.5 Non-Contact Cardiac Mapping Systems
4.1.3 Global Cardiac Mapping System Market demand by Indication
4.1.3.1 Market Overview
4.1.3.1.1 Atrial Fibrillation
4.1.3.1.2 Atrial Flutter
4.1.3.1.3 Atrioventricular Nodal Reentry Tachycardia (Avnrt)
4.1.3.1.4 Other Arrhythmias
4.1.4 Global Cardiac Mapping System Market by End-User
4.1.4.1 Market Overview
4.1.4.1.1 Hospitals
4.1.4.1.2 Testing Laboratories
4.1.4.1.3 Research Laboratories
4.1.4.1.4 Individual
4.1.5 Global Cardiac Mapping System by Region
4.1.5.1 Market Overview
4.1.5.1.1 North America
4.1.5.1.2 Europe
4.1.5.1.3 Asia Pacific
4.1.5.1.4 Latin America
4.1.5.1.5 Middle East & Africa
4.1.6 North America
4.1.6.1 Historical Trend (2016-2022)
4.1.6.2 Forecast Trend (2023-2031)
4.1.6.3 Break Up by Country
4.1.6.3.1 United States of America
4.1.6.3.2 Canada
4.1.7 Europe
4.1.7.1 Historical Trend (2016-2022)
4.1.7.2 Forecast Trend (2023-2031)
4.1.7.3 Break Up by Country
4.1.7.3.1 United Kingdom
4.1.7.3.2 Germany
4.1.7.3.3 France
4.1.7.3.4 Italy
4.1.7.3.5 Others
4.1.8 Asia Pacific
4.1.8.1 Historical Trend (2016-2022)
4.1.8.2 Forecast Trend (2023-2031)
4.1.8.3 Break Up by Country
4.1.8.3.1 China
4.1.8.3.2 Japan
4.1.8.3.3 India
4.1.8.3.4 ASEAN
4.1.8.3.5 Australia
4.1.8.3.6 Others
4.1.9 Latin America
4.1.9.1 Historical Trend (2016-2022)
4.1.9.2 Forecast Trend (2023-2031)
4.1.9.3 Break Up by Country
4.1.9.3.1 Brazil
4.1.9.3.2 Argentina
4.1.9.3.3 Mexico
4.1.9.3.4 Others
4.1.10 Middle East and Africa
4.1.10.1 Historical Trend (2016-2022)
4.1.10.2 Forecast Trend (2023-2031)
4.1.10.3 Break Up by Country
4.1.10.3.1 Saudi Arabia
4.1.10.3.2 United Arab Emirates
4.1.10.3.3 Nigeria
4.1.10.3.4 South Africa
4.1.10.3.5 Others
5 Trade Data Analysis by HS Code
6 Regulations and Current Scenario Evaluation
6.1 Regulatory Framework
6.2 Patent Landscape
6.3 Clinical Trials Synopsis (Additional Insight)
7 Industry Dynamics
7.1 Industry Drivers and Constraints
7.2 Porter Five Forces
7.3 SWOT Analysis
7.4 Key Demand Indicators
7.5 Key Price Indicators
7.6 Industry Events, Initiatives, and Trends
7.7 Value Chain Analysis
8 Supplier Landscape
8.1 Company Profiles
8.1.1 Biosense Webster
8.1.1.1 Company Overview
8.1.1.2 Product Portfolio
8.1.1.3 Demographic Reach and Achievements
8.1.1.4 Mergers and Acquisitions
8.1.1.5 Certifications
8.1.2 Abbott Laboratories
8.1.2.1 Company Overview
8.1.2.2 Product Portfolio
8.1.2.3 Demographic Reach and Achievements
8.1.2.4 Mergers and Acquisitions
8.1.2.5 Certifications
8.1.3 Medtronics PLC
8.1.3.1 Company Overview
8.1.3.2 Product Portfolio
8.1.3.3 Demographic Reach and Achievements
8.1.3.4 Mergers and Acquisitions
8.1.3.5 Certifications
8.1.4 Boston Scientific Corporation
8.1.4.1 Company Overview
8.1.4.2 Product Portfolio
8.1.4.3 Demographic Reach and Achievements
8.1.4.4 Mergers and Acquisitions
8.1.4.5 Certifications
8.1.5 Acutus Medical
8.1.5.1 Company Overview
8.1.5.2 Product Portfolio
8.1.5.3 Demographic Reach and Achievements
8.1.5.4 Mergers and Acquisitions
8.1.5.5 Certifications
8.1.6 Microport Scientific Corporation
8.1.6.1 Company Overview
8.1.6.2 Product Portfolio
8.1.6.3 Demographic Reach and Achievements
8.1.6.4 Mergers and Acquisitions
8.1.6.5 Certifications
8.1.7 CoreMap Inc.
8.1.7.1 Company Overview
8.1.7.2 Product Portfolio
8.1.7.3 Demographic Reach and Achievements
8.1.7.4 Mergers and Acquisitions
8.1.7.5 Certifications
8.1.8 APN Health LLC
8.1.8.1 Company Overview
8.1.8.2 Product Portfolio
8.1.8.3 Demographic Reach and Achievements
8.1.8.4 Mergers and Acquisitions
8.1.8.5 Certifications
8.1.9 BioSig Technologies Inc.
8.1.9.1 Company Overview
8.1.9.2 Product Portfolio
8.1.9.3 Demographic Reach and Achievements
8.1.9.4 Mergers and Acquisitions
8.1.9.5 Certifications
8.1.10 Biotronik SE and Co KG
8.1.10.1 Company Overview
8.1.10.2 Product Portfolio
8.1.10.3 Demographic Reach and Achievements
8.1.10.4 Mergers and Acquisitions
8.1.10.5 Certifications
8.1.11 Koninklijke Philips NV
8.1.11.1 Company Overview
8.1.11.2 Product Portfolio
8.1.11.3 Demographic Reach and Achievements
8.1.11.4 Mergers and Acquisitions
8.1.11.5 Certifications
8.1.12 Angiodynamics
8.1.12.1 Company Overview
8.1.12.2 Product Portfolio
8.1.12.3 Demographic Reach and Achievements
8.1.12.4 Mergers and Acquisitions
8.1.12.5 Certifications
9 Recommendations and Discussion
10 Pricing Models and Strategies (Additional Insight)
10.1 Overview
10.2 Cost Model
10.2.1 Manufacturing Cost Analysis
10.2.2 Procurement Cost Analysis
10.2.3 Clinical Trial Cost Factors
10.3 Pricing Strategies
10.3.1 Competitor pricing Analysis
10.3.2 Key assessment of product attributes
10.3.3 Pricing Benchmark
11 Global Cardiac Mapping System Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings